Cigna Group is contending with elevated industry-wide medical costs that are expected to weigh on its Healthcare segment in 2025, according to CFRA, which downgraded the stock to Hold in a note ...

Cigna delivered a knockout first quarter in 2025, prompting Raymond James to boost its price target from $360 to $385. The ...

ET on May 2Cigna is doubling down on its efforts to manage the challenges associated with GLP-1s through the launch of two ...

Cigna on Friday raised its full-year earnings forecast and beat estimates for quarterly profit, helped by strong performance ...